Carboxymethylcellulose Eye Solution (BRS Analytical) - Sterility Concern (2025)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Carboxymethlycellulose Sodium 0.5% Eye Lubricant, Lubricating Eye Drops, Moisturizing, Sterile, 0.5 FL OZ (15mL) per dropper bottle, Distributed by: AvKARE, Pulaski, TN 38478, NDC: 50268-068-15.
Brand
BRS Analytical Services, LLC
Lot Codes / Batch Numbers
Lot, expiry: Lot 103, exp 4/26/25, Lot 104, exp 5/03/25, Lot 108, exp 6/29/25, Lot 109, exp 7/18/25, Lot 110, exp 8/17/25, Lot 111, exp 8/22/25, Lot 112, exp 8/27/25, Lot 113, exp 9/18/25, Lot 125, exp 10/23/25, Lot 130, exp 11/09/25, Lot 131, exp 11/14/25, Lot 132, exp 11/27/25, Lot 133, exp 11/30/25, Lot 134, exp 12/05/25, Lot 135, exp 12/11/25, Lot 136, exp 12/14/25, Lot 137, exp 1/02/26, Lot 139, exp 1/15/26, Lot 140, exp 1/19/26, Lot 141, exp 1/25/26, Lot 151, exp 3/18/26, Lot 152, exp 3/21/26, Lot 153, exp 3/25/26, Lot 154, exp 3/28/26, Lot 155, exp 4/01/26, Lot 156, exp 4/08/26, Lot 157, exp 4/11/26, Lot 160, exp 4/26/26, Lot 180, exp 8/08/26, Lot 181, exp 8/12/26, Lot 182, exp 8/18/26, Lot 183, exp 8/21/26, Lot 184, exp 8/26/26, Lot 185, exp 9/04/26, Lot 186, exp 9/09/26, Lot 187, exp 9/16/26, Lot 188, exp 9/18/26, Lot 189, exp 9/21/26, Lot 190, exp 9/25/26, Lot 191, exp 9/28/26, Lot 192, exp 10/02/26, Lot 208, exp 12/11/26, Lot 209, exp 12/16/26, Lot 212, exp 1/15/27, Lot 213, exp 1/21/27, Lot 214, exp 1/24/27, Lot 215, exp 2/02/27, Lot 216, exp 2/04/27, Lot 224, exp 3/27/27.
Products Sold
Lot, expiry: Lot 103, exp 4/26/25; Lot 104, exp 5/03/25; Lot 108, exp 6/29/25; Lot 109, exp 7/18/25; Lot 110, exp 8/17/25; Lot 111, exp 8/22/25; Lot 112, exp 8/27/25; Lot 113, exp 9/18/25; Lot 125, exp 10/23/25; Lot 130, exp 11/09/25; Lot 131, exp 11/14/25; Lot 132, exp 11/27/25; Lot 133, exp 11/30/25; Lot 134, exp 12/05/25; Lot 135, exp 12/11/25; Lot 136, exp 12/14/25; Lot 137, exp 1/02/26; Lot 139, exp 1/15/26; Lot 140, exp 1/19/26; Lot 141, exp 1/25/26; Lot 151, exp 3/18/26; Lot 152, exp 3/21/26; Lot 153, exp 3/25/26; Lot 154, exp 3/28/26; Lot 155, exp 4/01/26; Lot 156, exp 4/08/26; Lot 157, exp 4/11/26; Lot 160, exp 4/26/26; Lot 180, exp 8/08/26; Lot 181, exp 8/12/26; Lot 182, exp 8/18/26; Lot 183, exp 8/21/26; Lot 184, exp 8/26/26; Lot 185, exp 9/04/26; Lot 186, exp 9/09/26; Lot 187, exp 9/16/26; Lot 188, exp 9/18/26; Lot 189, exp 9/21/26; Lot 190, exp 9/25/26; Lot 191, exp 9/28/26; Lot 192, exp 10/02/26; Lot 208, exp 12/11/26; Lot 209, exp 12/16/26; Lot 212, exp 1/15/27; Lot 213, exp 1/21/27; Lot 214, exp 1/24/27; Lot 215, exp 2/02/27; Lot 216, exp 2/04/27; Lot 224, exp 3/27/27.
BRS Analytical Services, LLC is recalling Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Carboxymethlycellulose Sodium 0.5% Eye Lubri due to cGMP deviations and lack of assurance of sterility.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
cGMP deviations and lack of assurance of sterility.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
This page aggregates publicly available data. Always confirm recall details directly with the U.S. Food and Drug Administration (FDA) before taking action.
View official FDA recall noticePage updated: Jan 7, 2026
Important Notice
This page displays information sourced from the U.S. Food and Drug Administration (FDA). IsMyProductRecalled.com aggregates public data for convenience and does not issue recalls. We are not affiliated with any government agency. Always verify recall information with the official source before taking action. This is not medical or legal advice.